Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
about
The enigmatic X gene of hepatitis B virusContributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesisStealth and cunning: hepatitis B and hepatitis C viruses.Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- StimulationPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells.The role of mutations in core protein of hepatitis B virus in liver fibrosisEvaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion methodH-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicityThe woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infectionHepatitis B virus-induced oncogenesis.Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.Pathogenesis of hepatitis B virus infectionAlpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgAntibody responses during hepatitis B viral infection.Factors associated with spontaneous clearance of hepatitis C virus in Chinese populationCoexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisMiRNA-548ah, a potential molecule associated with transition from immune tolerance to immune activation of chronic hepatitis B.Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic miceThe woodchuck model of hepatitis B virus infection.Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinomaImmunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo.Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.Hepatoimmunology: a perspective.Animal models of autoimmune liver disease.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India.Therapy of chronic hepatitis B: current challenges and opportunities.Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children.Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunityComplement C4a inhibits the secretion of hepatitis B virus screened by surface-enhanced laser desorption ionization time-flight mass spectrometry-based ProteinChip analysis.Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific.Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.Determinants of hepatitis B and delta virus host tropism.Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response.
P2860
Q24561887-8360FF45-A5A2-4692-83B4-A953E7ECE78AQ26775804-99C61A23-7EA5-4645-86DA-6772141BACFDQ27470232-CE045342-2A03-4BA0-AEB9-64BF577F0F19Q27481475-D8E07D8B-1B92-48BE-BEA2-D7D848843E2DQ28742762-92A48A78-F12B-42B0-820E-D13C67BCA8CDQ33200560-13706AE2-1ABE-4B45-BE51-D0B94C73360EQ33567791-83CCB6F5-6358-4C1F-B4B4-28E282BABB03Q33716406-3EE1657C-2E6D-41B0-8B56-80668E0F4E5EQ33754985-2694A4A8-AEE1-4160-9E5D-81EA1257FC4DQ33787525-D352C80F-5EEC-483D-AC09-F6EA81E0C9C9Q33787553-DDB7486F-5E1C-47B5-9C29-241DA1A5F496Q33899640-C412D51F-DFB6-4731-90D2-7BECACB13F0FQ33925491-08E3AB82-C36C-48D8-9D47-D2D0EE4436DAQ33930340-85148BBD-2AF1-4A6D-AE2F-6FEC8ADC8923Q33981600-4C5703F0-EEB7-473A-A61D-94861D300B08Q34009690-EEC45E7A-30E4-4B4C-8C00-388C5A85BFCFQ34057979-43303419-BA2E-4E6B-A974-BA6740DA8BD7Q34068117-85BD4E88-E9AD-48F2-8815-9A6694ADC2E4Q34158620-081C19DA-D234-4F26-B96C-BFE4A816916FQ34228477-D7BAB59D-6E83-4A03-83EC-F18B602F87ECQ34282796-A76FC3CE-800B-4EB2-9982-28EAABF44F7AQ34343960-680CB2FF-5291-408F-934C-B344B11A41FFQ34344082-0E6C6824-A90F-463B-95B2-3EFED7A2DF02Q34354287-F459D299-70A6-43CD-86D3-230FEC05D4A6Q34365631-CD82A733-F14A-42CC-BADB-273ABEA2933CQ34462354-C44E1F2A-8427-43F4-8494-2C30A06C2914Q34546424-96BF08D7-8C9F-4247-B5FC-A2874567BE79Q34546465-F736EF1A-3514-4184-9320-98D12ACC9128Q34785204-B6B47522-D098-42B3-8865-FA7CA2689390Q34825656-D85FBBBC-50B5-4942-BF25-23575A3F4795Q34996613-65C10D5E-1E7D-4AB5-AAFF-0E048EFB0CFAQ35000423-359B8024-0996-4BF1-8888-E7D009F77669Q35072187-DF6958D6-572B-42B7-82F5-E7B0496B5534Q35076712-8309A9E4-7427-4E8E-8B55-8EB6DAEC2EA8Q35634911-CA2FCC53-79ED-4502-B919-F7BC301AD2D0Q35676625-B94663DC-7BAC-43AF-AB3D-B5312577139AQ35688341-4096AEFA-3CF6-4300-9AAB-BCBFCC61C63BQ35951737-A64419BD-1D0B-4CF3-B3F7-396F49EE58E1Q35998324-91F15A7D-E3ED-4C62-BA57-3B44A21FBA16Q36011955-934112D0-E7CE-43AB-9327-39C9D0F9ABDC
P2860
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@ast
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@en
type
label
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@ast
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@en
prefLabel
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@ast
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@en
P2860
P1476
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B
@en
P2093
F V Chisari
P2860
P304
P356
10.1016/S0002-9440(10)64980-2
P407
P577
2000-04-01T00:00:00Z